Search

Home > Research > Research Units > Lung Infection & Immunity Unit
Research Units

Lung Infection & Immunity Unit

Lung Infection & Immunity Unit

About us

The UCTLI is nearing the end of its ninth year of operation, and its growth both in terms of projects and budget (of more than 20% year on year) show no signs of slowing. More clinical research units have been formed in response to the need and opportunities for addressing health issues in Southern Africa. The relevance of the research will be evident from the brief summary provided below. Details of the six Clinical Research Units and their current projects can be viewed on the new Institute website www.lunginstitute@co.za. The Institute was reconstituted and in January 2007 became a wholly owned subsidiary of the University of Cape Town, but retains its separate corporate identity, administration, staffing and finance. It benefits from strong representation from the university on its Board and finance committee, and collaborations in research with many units and departments in the Health Sciences Faculty. These links provide substance to the aim of the Institute to serve as an extended platform for the Faculty for teaching, learning and research. Its distinctive contribution however is that its independence provides flexibility to engage in implementation research and service contracts with parties such as departments of health and other funders since its goals extend beyond the academic, into community-based health interventions, strategic development of new treatments and other innovative approaches to health.

The Institute is served by a Management Committee which oversees the day to day management of the Institute comprising the heads of the Clinical Research Units, the manager and financial advisor, and a Finance Committee both of which report to the Board. As Managing Director I am grateful for the excellent service and commitment of members of these committees which have enabled the Institute to function with a high degree of efficiency and accountability and in conformity with accepted business standards. This in term has created maximum opportunity for researchers, teachers and learners to remain focused and productive, for which the publication record of the various CRUs provided at the end of this report serves an appropriate index. While the number and quality of the publications is pleasing it is their scope and relevance to medical science in South Africa that commends them most. I wish to record my gratitude and thanks to every member of the Lung Institute in whatever capacity they have served for their contribution to the Institute over the last two years. Special thanks is due to the directors who serve in an honorary capacity providing valuable guidance and support.